Twitxy
Saved
@divijmathew's profile picture
View on X

Divij

@divijmathew

PostDoc in the Wherry Lab @ UPenn.
UPenn linkedin.com/in/divijmathew Joined September 2009
284 Following 240 Followers 129 Posts

Latest posts 5

Pinned post

Divij @divijmathew
extremely excited to share our new story on the impact of JAK inhibition on responses to immune checkpoint blockade in lung cancer patients! 🧬🧑‍🔬 thread on our main findings 🧵 1/n
science.org/doi/10.1126/sc…
www.science.org Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients Persistent inflammation driven by cytokines such as type-one interferon (IFN-I) can cause immunosuppression. We show that administration of the Janus kinase 1 (JAK1) inhibitor itacitinib after...
11 replies 27 reposts 104 likes 23K views View on X
Divij @divijmathew
I’m honored to be part of the PICI community and I look forward to engaging this network of scientist in tackling challenges in Cancer Immunotherapy. @parkerici
My utmost gratitude to @PennMedicine, @EJohnWherry and @WherryLab for providing an environment to pursue this science
Parker Institute Verified account @parkerici Jun 27, 2023
We proudly announce our 2023 Early Career Researcher awardees. Since 2016, PICI has provided more than $20 million in funding to train and empower the scientific leaders of tomorrow. Learn more: parkerici.org/the-latest/ecr…
View quoted post on X
1 replies 2 reposts 26 likes 4.8K views View on X
Divij @divijmathew
Congrats to the talented Dr. Baxter on an amazing body of work! @amylizbaxter
Dr. Amy Baxter @amylizbaxter Jun 14, 2023
Super excited to share our work on the differential roles of distinct versions of SWI/SNF chromatin remodelling complexes in CD8 T cell exhaustion! A huge team effort from labs of @EJohnWherry , Martha Jordan and @junwei_s. doi.org/10.1016/j.immu…
View quoted post on X